M&A news last week featured French pharma major Sanofi announcing an agreement to acquire US vaccine maker Dynavax ...

Seattle, USA-based biotech Omeros Corp saw its shares leap 75.5% to $15.36 by close of trading Wednesday, as it revealed that ...

French pharma major Sanofi (Euronext: SAN) has received a Complete Response Letter (CRL) from the US regulator for ...

By Emma Banks, chief executive at ramarketing If I had to describe 2025 in one phrase, it would be this: a year of two halves ...

Artificial intelligence remains the most impactful technology shaping the pharmaceutical industry, with companies ...

Australian regulator the Therapeutic Goods Administration (TGA) has received an internationally recognized designation from ...

Japanese pharma major Shionogi announced the conclusion of a joint research and development agreement and investment ...

French pharma major Sanofi today revealed it has agreed to acquire Dynavax Technologies, a US vaccines company with a ...

Neok Biotech’s $75 million series A venture round, which took the California-based biotech out of stealth mode, was not the ...

China’s rise as a biopharma innovator is reshaping global drug development, underpinned by regulatory reform and a rapidly ...

US biotech Altimmune (Nasdaq: ALT) said its experimental MASH drug pemvidutide delivered sustained improvements in key ...

German biosimilars specialist Formycon (FWB: FYB) has won US approval for Nufymco (ranibizumab), an interchangeable ...